|
1
|
Ramírez-Soto MC, Ortega-Cáceres G and
Cabezas C: Trends in mortality burden of hepatocellular carcinoma,
cirrhosis, and fulminant hepatitis before and after roll-out of the
first pilot vaccination program against hepatitis B in Peru: An
analysis of death certificate data. Vaccine. 35:3808–3812. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization: Hepatitis B
vaccines: WHO position paper, July 2017-Recommendations. Vaccine.
37:223–225. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fairman J, Liu KH and Menne S: Prevention
of liver tumor formation in woodchucks with established
hepatocellular carcinoma by treatment with cationic liposome-DNA
complexes. BMC Cancer. 17:1722017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qin B, Zhou Y, Zhou G, Xu X, Wang Y and
Chen J: Substitutions of rtL228 and/or L229 are involved in the
regulation of replication and HBsAg secretion in hepatitis B virus,
and do not affect susceptibility to nucleos(t)ide analogs. Mol Med
Rep. 16:9678–9684. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li W: The hepatitis B virus receptor. Annu
Rev Cell Dev Biol. 31:125–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan H and Li W: Sodium taurocholate
cotransporting polypeptide acts as a receptor for hepatitis B and D
virus. Dig Dis. 33:388–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni Y, Lempp FA, Mehrle S, Nkongolo S,
Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, et al:
Hepatitis B and D viruses exploit sodium taurocholate
co-transporting polypeptide for species-specific entry into
hepatocytes. Gastroenterology. 146:1070–1083. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou M, Zhao K, Yao Y, Yuan Y, Pei R, Wang
Y, Chen J, Hu X, Zhou Y, Chen X and Wu C: Productive HBV infection
of well-differentiated, hNTCP-expressing human hepatoma-derived
(Huh7) cells. Virol Sin. 32:465–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He W, Ren B, Mao F, Jing Z, Li Y, Liu Y,
Peng B, Yan H, Qi Y, Sun Y, et al: Hepatitis D virus infection of
mice expressing human sodium taurocholate co-transporting
polypeptide. PLoS Pathog. 11:e10048402015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blank A, Markert C, Hohmann N, Carls A,
Mikus G, Lehr T, Alexandrov A, Haag M, Schwab M, Urban S and
Haefeli WE: First-in-human application of the novel hepatitis B and
hepatitis D virus entry inhibitor myrcludex B. J Hepatol.
65:483–489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaneko M, Watashi K, Kamisuki S, Matsunaga
H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, et
al: A Novel tricyclic polyketide, Vanitaracin A, specifically
inhibits the entry of hepatitis B and D viruses by targeting sodium
taurocholate cotransporting polypeptide. J Virol. 89:11945–11953.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Meyer S, Gong ZJ, Suwandhi W, van Pelt
J, Soumillion A and Yap SH: Organ and species specificity of
hepatitis B virus (HBV) infection: A review of literature with a
special reference to preferential attachment of HBV to human
hepatocytes. J Viral Hepat. 4:145–153. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu X, Yan Q, Wang Y and Dong X: NTN4 is
associated with breast cancer metastasis via regulation of
EMT-related biomarkers. Oncol Rep. 37:449–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin B, Budeus B, Cao L, Wu C, Wang Y,
Zhang X, Rayner S, Hoffmann D, Lu M and Chen X: The amino acid
substitutions rtP177G and rtF249A in the reverse transcriptase
domain of hepatitis B virus polymerase reduce the susceptibility to
tenofovir. Antiviral Res. 97:93–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Esparza-López J, Ramos-Elías PA,
Castro-Sánchez A, Rocha-Zavaleta L, Escobar-Arriaga E,
Zentella-Dehesa A, León-Rodríguez E, Medina-Franco H and
Ibarra-Sánchez MJ: Primary breast cancer cell culture yields
intra-tumor heterogeneous subpopulations expressing exclusive
patterns of receptor tyrosine kinases. BMC Cancer. 16:7402016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naipal KA, Verkaik NS, Sánchez H, van
Deurzen CH, den Bakker MA, Hoeijmakers JH, Kanaar R, Vreeswijk MP,
Jager A and van Gent DC: Tumor slice culture system to assess drug
response of primary breast cancer. BMC Cancer. 16:782016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Y, Burns DJ, Rich BE, MacNeil IA,
Dandapat A, Soltani SM, Myhre S, Sullivan BF, Lange CA, Furcht LT
and Laing LG: Development of a test that measures real-time HER2
signaling function in live breast cancer cell lines and primary
cells. BMC Cancer. 17:1992017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD,
Sun YL, Zhang L, Zhang QF, Popov VL, Li C, et al: Fever with
thrombocytopenia associated with a novel bunyavirus in China. N
Engl J Med. 364:1523–1532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Santos AP, Levi JE, Lemos MF, Calux SJ,
Oba IT and Moreira RC: An in-house real-time polymerase chain
reaction: Standardisation and comparison with the Cobas Amplicor
HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the
quantification of hepatitis B virus DNA. Mem Inst Oswaldo Cruz.
111:134–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salpini R, Piermatteo L, Gill U, Battisti
A, Stazi F, Guenci T, Giannella S, Serafini V, Kennedy PTF, Perno
CF, et al: Quantification of intrahepatic total HBV DNA in liver
biopsies of HBV-infected patients by a modified version of
COBAS® Ampliprep/COBAS®TaqMan HBV test v2.0.
Med Microbiol Immunol. 206:295–299. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kohls K, Schmidt D, Holdenrieder S, Müller
SC and Ellinger J: Detection of cell-free lncRNA in serum of cancer
patients. Urologe A. 54:819–825. 2015.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hayes CN, Zhang Y, Makokha GN, Hasan MZ,
Omokoko MD and Chayama K: Early events in hepatitis B virus
infection: From the cell surface to the nucleus. J Gastroenterol
Hepatol. 31:302–309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pei R, Qin B, Zhang X, Zhu W, Kemper T, Ma
Z, Trippler M, Schlaak J, Chen X and Lu M: Interferon-induced
proteins with tetratricopeptide repeats 1 and 2 are cellular
factors that limit hepatitis B virus replication. J Innate Immun.
6:182–191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Helgstrand JT, Røder MA, Klemann N, Toft
BG, Lichtensztajn DY, Brooks JD, Brasso K, Vainer B and Iversen P:
Trends in incidence and 5-year mortality in men with newly
diagnosed, metastatic prostate cancer-A population-based analysis
of 2 national cohorts. Cancer. 124:2931–2938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY,
Chen XY, Liu QL, Peng L, Li JG, Mei YY, et al: Allogeneic bone
marrow-derived mesenchymal stromal cells for hepatitis B
virus-related acute-on-chronic liver failure: A randomized
controlled trial. Hepatology. 66:209–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei XL, Qiu MZ, Chen WW, Jin Y, Ren C,
Wang F, Luo HY, Wang ZQ, Zhang DS, Wang FH, et al: The status of
HBV infection influences metastatic pattern and survival in Chinese
patients with pancreatic cancer. J Transl Med. 11:2492013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morales-Romero J, Vargas G and
García-Román R: Occult HBV infection: A faceless enemy in liver
cancer development. Viruses. 6:1590–1611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tajima K, Takahashi N, Ishizawa K, Murai
K, Akagi T, Noji H, Sasaki O, Wano M, Itoh J, Kato Y, et al: Tohoku
Hematology Forum: High prevalence of diffuse large B-cell lymphoma
in occult hepatitis B virus-infected patients in the Tohoku
district in Eastern Japan. J Med Virol. 88:2206–2210. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan H, Liu Y, Sui J and Li W: NTCP opens
the door for hepatitis B virus infection. Antiviral Res. 121:24–30.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bility MT, Li F, Cheng L and Su L: Liver
immune-pathogenesis and therapy of human liver tropic virus
infection in humanized mouse models. J Gastroenterol Hepatol. 28
(Suppl 1):S120–S124. 2013. View Article : Google Scholar
|
|
33
|
Watashi K and Wakita T: Hepatitis B virus
and hepatitis D virus entry, species specificity, and tissue
tropism. Cold Spring Harb Perspect Med. 5:a0213782015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Summers J and Mason WS: Replication of the
genome of a hepatitis B-like virus by reverse transcription of an
RNA intermediate. Cell. 29:403–415. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bai L, Zhang X, Kozlowski M, Li W, Wu M,
Liu J, Chen L, Zhang J, Huang Y and Yuan Z: Extracellular hepatitis
B virus RNAs are heterogeneous in length and circulate as
capsid-antibody complexes in addition to virions in chronic
hepatitis B patients. J Virol. 92:e00798–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dandri M and Locarnini S: New insight in
the pathobiology of hepatitis B virus infection. Gut. 61 (Suppl
1):i6–i17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakamoto Y and Kaneko S: Mechanisms of
viral hepatitis induced liver injury. Curr Mol Med. 3:537–544.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu WC and Liu QY: Molecular mechanisms of
gender disparity in hepatitis B virus-associated hepatocellular
carcinoma. World J Gastroenterol. 20:6252–6261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suba Z: Circulatory estrogen level
protects against breast cancer in obese women. Recent Patents
Anticancer Drug Discov. 8:154–167. 2013. View Article : Google Scholar
|
